Sign inJoin waitlistJoin the waitlist

MF

Marshall Fordyce

Credentials: · ·

History

Infectious Disease
Columbia Univ Coll of Phys & Surgeons
2010–2011
Internal Medicine
New York University Medical Center
2007–2010
Doctor of Medicine
2003–2007

Research

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised,…
The Lancet · 2015 · 509 citations
Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
Review · Antiviral Research · 2016 · 316 citations
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults
Journal of acquired immune deficiency syndromes · 2013 · 267 citations

GC
Gordon Crofoot
5 papers
MD
Moupali Das
5 papers
ED
Edwin Dejesus
4 papers
JG
Joseph Gathe
3 papers
Karen Tashima
3 papers
Pablo Tebas
3 papers
Paul Sax
3 papers
Will Garner
3 papers · 3 as a resident
CB
Cynthia Brinson
2 papers
David Wohl
2 papers
FT
Frank Tomaka
2 papers
Grace McComsey
2 papers

Clinical trials

Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
Study director · Completed · Phase 3
Gilead Sciences
2011–2015
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Study director · Completed · Phase 3
Gilead Sciences
2010–2014